Greece gives pharma sector a price-cut remedy after lobbying efforts
This article was originally published in Scrip
Executive Summary
The Greek ministry of commerce appears to be giving the pharmaceutical industry room for manoeuvre in its price cut plans. In April, it issued a market decree which would see medicine prices cut by 3-27%, but it has now issued a letter dated 19 May to three industry associations representing the R&D (SFEE), generics (PEF) and the OTC sectors (EFEX), saying that companies will be allowed to submit a "petition for remedy" or appeal against these price cuts.